Date: 2025/05/16 - 14:31
Significant adverse events — such as ARIA — with lecanemab, the drug that slows Alzheimer's, is rare and manageable, “real-world” data from people with mild Alzheimer's disease shows.
Date: 2025/05/15 - 21:30
NIH-supported gene-editing platform lays groundwork to rapidly develop treatments for other rare genetic diseases.
Date: 2025/05/13 - 23:32
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide, exenatide, and dulaglutide were 41% more effective at preventing obesity-related cancers.
Date: 2025/05/12 - 19:31
A class of HIV drugs known as nucleotide reverse transcriptase inhibitors (NRTIs) may help prevent Alzheimer’s disease, reducing risk by up to 13%, a new study suggests.
Date: 2025/05/08 - 20:00
Despite increasing incidence rates, cancer deaths in young people have not increased overall.
Date: 2025/05/07 - 17:00
The partnership will focus first on enabling research around the root causes of autism spectrum disorder.
Date: 2025/05/07 - 00:31
Probiotics may help improve a person's daily mood and, if taken regularly for about 2 weeks, could help reduce negative feelings, more broadly.
Digitally engaging with technology correlated to a 58% lower risk of cognitive impairment, contrary to fears of “digital dementia,” a new meta-analysis has found.
People aged over 45 who needed acute hospital care due to heavy cannabis use had a 72% greater risk of developing dementia within 5 years than the general population.
Some risk factors and blood biomarkers related to Alzheimer's disease and cognitive impairment can be detected as early as age 24, according to a recent study.